MktsMarkets

Amneal Pharmaceuticals, Inc.
NASDAQ: AMRXKey statistics
AMRX News
Stories mentioning AMRX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 722,519 | 814,319 | 784,513 | 724,508 | 695,420 | 730,518 | 702,468 | 701,780 |
| Cost of Goods Sold | 402,406 | 517,129 | 510,539 | 438,255 | 439,529 | 467,645 | 432,910 | 451,833 |
| Gross Profit | 320,113 | 297,190 | 273,974 | 286,253 | 255,891 | 262,873 | 269,558 | 249,947 |
| Operating Expenses | ||||||||
| Research & Development | 38,383 | 34,819 | 63,352 | 47,964 | 40,040 | 54,265 | 61,097 | 36,054 |
| Sales General & Admin | 138,860 | 146,458 | 137,815 | 124,266 | 118,288 | 128,687 | 118,692 | 116,462 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 141,772 | 112,033 | 70,344 | 111,372 | 100,347 | 75,793 | 88,809 | 95,470 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 742.00 | 13,165 | 1,235 | 1,604 | 518.00 | 2,172 | 1,178 | 4,360 |
| Pretax Income | 80,176 | 55,235 | (5,223) | 51,711 | 37,486 | (15,319) | 15,423 | 20,405 |
| Tax Provision | 2,176 | 5,662 | (23,355) | 16,101 | 12,868 | 5,423 | 3,666 | 3,618 |
| Net Income (Loss) | 62,256 | 35,076 | 2,369 | 22,417 | 12,195 | (31,081) | (156.00) | 5,994 |
| Earnings Per Share (Basic) | 0.20 | 0.11 | 0.01 | 0.07 | 0.04 | (0.10) | 0.00 | 0.02 |
| Earnings Per Share (Diluted) | 0.19 | 0.11 | 0.01 | 0.07 | 0.04 | (0.10) | 0.00 | 0.02 |
| Weighted Average Shares Outstanding (Basic) | 316,023 | 313,367 | 314,168 | 313,739 | 311,054 | 308,978 | 309,647 | 309,117 |
| Weighted Average Shares Outstanding (Diluted) | 328,933 | 324,805 | 324,754 | 322,363 | 323,961 | 308,978 | 309,647 | 318,957 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About AMRX
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol AMRX. It last traded at $21.38 (Nov 10, 2026, 4:00 PM ET), up 0.5% on the day. That gives Amneal Pharmaceuticals a market capitalisation of $7.5B and a price-to-earnings ratio of 56.1.
Over the past 52 weeks AMRX has traded between $11.29 and $21.68.
Revenue for the quarter ended Mar 31, 2026 was $722.5M; net income $62.3M. Revenue was up 3.9% from $695.4M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $722.5M | $62.3M | 8.6% |
| Dec 31, 2025 | $814.3M | $35.1M | 4.3% |
| Sep 30, 2025 | $784.5M | $2.4M | 0.3% |
| Jun 30, 2025 | $724.5M | $22.4M | 3.1% |
From Amneal Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…